A Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN) (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=25 | Not yet recruiting | Sponsor: Biogen
New P2 trial • Glomerulonephritis • IgA Nephropathy • Renal Disease
|